Inicio > BIGG > Resultado de la búsqueda

    Resultados: 3

    AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity

    Grunvald, Eduardo; Shah, Raj; Hernaez, Ruben; Chander, Apoorva Krishna; Teigen, Levi M; Sultan, Shahnaz; Sigh, Siddarth; Daviikov, Perica.
    Gastroenterology; 163 (5), 2022
    Pharmacological management of obesity improves outcomes and decreases the risk of obesity-related complications. This American Gastroenterological Association guideline is intended to support practitioners in decisions about pharmacological interventions for overweight and obesity. A multidisciplinary pa...
    Factores de Riesgo de Enfermedad Cardiaca, Resistencia a la Insulina, Obesidad/tratamiento farmacológico, Depresores del Apetito, Hipoglucemiantes/uso terapéutico, Diabetes Mellitus Tipo 2/prevención & control, Topiramato/uso terapéutico, Fármacos Antiobesidad/uso terapéutico
    Texto completo

    Pharmacotherapy for obesity management

    Wharton, Sean; Manjoo, Priya; Pedersen, Sue D.
    Pharmacological treatments are an effective and scalable approach to treating obesity. As with any chronic disease, such as type 2 diabetes (T2DM) or hypertension, pharmacotherapy is an important pillar in the management of obesity. The focus of obesity management should be the improvement of health para...
    Obesidad/tratamiento farmacológico, Manejo de la Obesidad, Fármacos Antiobesidad/uso terapéutico
    Texto completo

    Pharmacological management of obesity: an Endocrine Society clinical practice guideline

    Apovian, C. M; Aronne, L. J; Bessesen, D. H; McDonnell, M. E; Murad, M. H; Pagotto, U; Ryan, D. H; Still, C. D.
    J. clin. endocrinol. metab; 100 (2), 2015
    OBJECTIVE: To formulate clinical practice guidelines for the pharmacological management of obesity. PARTICIPANTS: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. This guideline was co-sponsored by the European Society of Endocrinology and The Obesity Society. ...
    Obesidad/tratamiento farmacológico, Diabetes Mellitus/etiología, Depresión/etiología, Serotoninérgicos/uso terapéutico, Dopaminérgicos/uso terapéutico, Norepinefrina/uso terapéutico, Fentermina/uso terapéutico, Bupropión/uso terapéutico, Naltrexona/uso terapéutico, Péptido 1 Similar al Glucagón/agonistas
    Texto completo